UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

The Individualized Treatment of Opioid Use Disorder

Journal of managed care & specialty pharmacy, 2019-06, Vol.25 (6), p.634

Boyett, Brent

2019

Link zum Volltext

Verfügbarkeit prüfen

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

Frontiers in psychiatry, 2021-03, Vol.12, p.623403-623403

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2019-02, Vol.393 (10173), p.778-790

2019

Link zum Volltext

Verfügbarkeit prüfen

Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection

The American journal of drug and alcohol abuse, 2023-01, Vol.49 (1), p.43-52

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (3), p.282

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS

Drug and alcohol dependence, 2021-12, Vol.229 (Pt B), p.109057-109057, Article 109057

2021

Link zum Volltext

Verfügbarkeit prüfen

18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies

Journal of substance use and addiction treatment, 2023-11, Vol.154, p.209155-209155, Article 209155

2023

Link zum Volltext

Verfügbarkeit prüfen

Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings

Journal of addiction medicine, 2023-03, Vol.17 (2), p.182

2023

Link zum Volltext

Verfügbarkeit prüfen

Death by Opioids: Are there non-addictive scientific solutions?

Journal of systems and integrative neuroscience, 2019-06, Vol.5 (2)

2019

Link zum Volltext

Verfügbarkeit prüfen

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2646-2654

2015

Link zum Volltext

Verfügbarkeit prüfen

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

The New England journal of medicine, 2010-05, Vol.362 (18), p.1675-1685

2010

Link zum Volltext

Verfügbarkeit prüfen

Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children

Neuro-oncology (Charlottesville, Va.), 2015-06, Vol.17 (6), p.882-888

2015

Link zum Volltext

Verfügbarkeit prüfen

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

Gastroenterology (New York, N.Y. 1943), 2023-08, Vol.165 (2), p.463

2023

Link zum Volltext

Verfügbarkeit prüfen

Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease

Human pathology, 2012-06, Vol.43 (6), p.790-800

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(10)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(10)
Female
(7)
Male
(7)
Adult
(4)
Middle Aged
(4)
Opioid Use Disorder
(4)
Substance Abuse
(4)
Analgesics, Opioid - Therapeutic Use
(3)
Buprenorphine
(3)
Buprenorphine - Therapeutic Use
(3)
General & Internal Medicine
(3)
Medicine, General & Internal
(3)
Narcotics
(3)
Opioid-Related Disorders - Drug Therapy
(3)
Opioids
(3)
Substance Use Disorder
(3)
Addiction
(2)
Biological And Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Individualized Treatment of Opioid Use Disorder

Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Open-label, rapid initiation pilot study for extended-release buprenorphine subcutaneous injection

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial

Assessment of craving in opioid use disorder: Psychometric evaluation and predictive validity of the opioid craving VAS

18-Month efficacy and safety analysis of monthly subcutaneous buprenorphine injection for opioid use disorder: Integrated analysis of phase 3 studies

Continued Posttrial Benefits of Buprenorphine Extended Release: RECOVER Study Findings

Death by Opioids: Are there non-addictive scientific solutions?

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease

Suchergebnisse filtern